原代肾小管上皮细胞Toll样受体9通路激活后的转录组变化
研究提取并培养小鼠原代肾小管上皮细胞,细胞融合度达80%时分为PBS对照组与终浓度5 μmol/L CpG-ODN处理组,提取RNA后经Illumina平台测序,用DEGseq分析差异基因、Goatools与KOBAS分析信号通路、Homer预测转录因子。结果显示CpG-ODN处理组较PBS对照组共584个差异表达基因,其中102个上调、482个下调;最显著富集的GO条目包括对干扰素-β的反应、对病毒的防御反应等炎症通路,最显著富集的KEGG通路包括2'-5'-寡腺苷酸合成酶活性、核糖核酸酶活性调节、病毒生命周期负调控、细胞对干扰素-β的反应及对原虫的防御反应。转录因子预测显示IRF3是差异基因启动子序列中最显著富集的转录因子,也是TLR9下游最显著的转录因子,TCF21、ZNF135、PRDM4可能是TLR9信号通路的新候选转录因子。作者认为该结果为深入研究TLR9通路在脓毒症诱导急性肾损伤中的分子机制提供了基础。
要点
- 小鼠原代肾小管上皮细胞融合度达80%后,PBS对照组加10 μL PBS,处理组加终浓度5 μmol/L的CpG-ODN。
- CpG-ODN处理组较PBS对照组共584个差异表达基因,其中102个上调、482个下调。
- 差异基因最显著富集的GO条目包括对干扰素-β的反应、对病毒的防御反应等炎症通路。
- 最显著富集的KEGG通路包括2'-5'-寡腺苷酸合成酶活性、核糖核酸酶活性调节、病毒生命周期负调控、细胞对干扰素-β的反应及对原虫的防御反应。
- IRF3是差异基因启动子序列中最显著富集的转录因子,也是TLR9下游最显著的转录因子;TCF21、ZNF135、PRDM4可能是TLR9信号通路的新候选转录因子。
适用人群与场景
- 小鼠原代肾小管上皮细胞,细胞融合度达80%时进入实验分组。
处置流程与药物剂量
- 细胞融合度达80%时分为两组:PBS对照组加入10 μL PBS;CpG-ODN处理组加入TLR9激活剂CpG-ODN至终浓度5 μmol/L。
研究设计与关键结果
- 实验为小鼠原代肾小管上皮细胞体外研究:PBS对照组与CpG-ODN处理组(终浓度5 μmol/L)比较,提取RNA后经Illumina平台测序。
- CpG-ODN处理组较PBS对照组共584个差异表达基因,其中102个上调、482个下调。
- 差异基因最显著富集的GO条目包括对干扰素-β的反应、对病毒的防御反应等炎症通路。
- 最显著富集的KEGG信号通路包括2'-5'-寡腺苷酸合成酶活性、核糖核酸酶活性调节、病毒生命周期负调控、细胞对干扰素-β的反应及对原虫的防御反应。
- 转录因子预测显示IRF3是差异基因启动子序列中最显著富集的转录因子,也是TLR9下游最显著的转录因子;TCF21、ZNF135、PRDM4可能是TLR9信号通路的新候选转录因子。
证据类型、等级与局限
- 证据类型:体外细胞实验(小鼠原代肾小管上皮细胞RNA测序)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the effect of Toll-like receptor 9 (TLR9) signaling pathway activation on the transcriptome in the renal tubular cells.
METHODS: Mouse primary renal tubular epithelial cells were extracted and cultured. When the degree of cell fusion reached 80%, they were divided into two groups, which were added with 10 μL phosphate buffered saline (PBS, PBS control group) and TLR9 activator cytosine phosphate guanidine oligodeoxynucleotide (CpG-ODN) with a final concentration of 5 μmol/L (CpG-ODN treatment group). The RNA sequencing was performed on the Illumina platform after extraction. DEGseq software was used to analyze the differential expression of genes between the two groups. Goatools and KOBAS online software were used to analyze the differential genes involved signal pathways. Homer software was used to predict transcription factors.
RESULTS: Compared with the PBS control group, there were a total of 584 differentially expressed genes in the CpG-ODN treatment group, of which 102 were up-regulated and 482 were down-regulated. The most significantly enriched gene ontology (GO) terms of differentially expressed genes included response to interferon-β, defense response to virus and other inflammatory pathway. The most significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways included 2'-5'-oligoadenylate synthase activity, regulation of ribonuclease activity, negative regulation of virus life cycle, cellular response to interferon-βand defense response to protozoan. The results of transcription factor prediction showed that interferon regulatory factor 3 (IRF3) was the most significantly enriched transcription factor in the promoter sequence of differential genes; the most significant transcription factor downstream of TLR9 was IRF3, and other predicted transcription factors such as transcription factor 21 (TCF21), zinc finger protein 135 (ZNF135), and PR domain containing 4 (PRDM4) might be new candidates for TLR9 signaling pathway.
CONCLUSIONS: CpG-ODN activates TLR9 signaling pathway, and primary renal tubular epithelial cells can directly respond to CpG-ODN stimulation and undergo transcriptome changes, which provides a basis for further research on the molecular mechanism of TLR9 pathway in sepsis induced acute kidney injury.
参考来源
- Li Y, Xu D, Zhang J, et al. [Transcriptome changes upon Toll-like receptor 9 pathway activation in primary renal tubular epithelial cells]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35692205. doi:10.3760/cma.j.cn121430-20220228-00183
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。